Effect of Prepro-Calcitonin Gene-Related Peptide-Expressing Endothelial Progenitor Cells on Pulmonary Hypertension

Annals of Thoracic Surgery

Volumn 84, Issue 2, 2007, Pages 544-552

  Zhao, Qiang ^a   Liu, Zixiong ^a   Wang, Zhe ^a   Yang, Cheng ^a   Liu, Jun ^a   Lu, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; PREPROCALCITONIN GENE RELATED PEPTIDE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HEART CATHETERIZATION; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; INFERIOR CAVA VEIN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA, ABDOMINAL; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; HUMANS; HYPERTENSION, PULMONARY; PROTEIN PRECURSORS; PULMONARY ARTERY; RATS; RATS, NUDE; RENAL ARTERY; STEM CELLS;

EID: 34447570619     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.03.067     Document Type: Article

References (31)

1. Morrell N.W., Yang X., Upton P.D., et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins. Circulation 104 (2001) 790-795
2. Provencher S., Jais X., Yaici A., et al. Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture. Chest 128 6 Suppl (2005) 622-628
3. Sladkova H., Jansa P., Susa Z., et al. Pathophysiology and classification of pulmonary hypertension. Vnitr Lek 50 (2004) 685-688
4. Karoli N.A., and Rebrov A.P. A role of the endothelium in the development of pulmonary hypertension in patients with chronic obstructive lung diseases. Klin Med (Mosk) 82 (2004) 8-14
5. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
6. Luttun A., Carmeliet G., and Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 12 (2002) 88-96
7. Champion H.C., Bivalacqua T.J., Pierce R.L., et al. Responses to human CGRP, ADM, and PAMP in human thymic arteries. Am J Physiol Regul Integr Comp Physiol 284 (2003) R531-R537
8. Qing X., and Keith I.M. Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats. Am J Physiol Lung Cell Mol Physiol 285 (2003) L86-L96
9. Champion H.C., Bivalacqua T.J., Toyoda K., et al. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101 (2000) 923-930
10. Murohara T., Ikeda H., Duan J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105 (2000) 1527-1536
11. Harraz M., Jiao C., Hanlon H.D., et al. CD34- blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
12. Boyer M., Townsend L.E., Vogel L.M., et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 31 (2000) 181-189
13. Kalka C., Masuda H., Takahashi T., et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 (2000) 1198-1202
14. Reyes M., Dudek A., Jahagirdar B., et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 (2002) 337-346
15. Wang F.S., Rowan R.M., Creer M., et al. Detecting human CD34+ and CD34- hematopoietic stem and progenitor cells using a Sysmex automated hematology analyzer. Lab Hematol 10 (2004) 200-205
16. Hristov M., and Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8 (2004) 498-508
17. Mutin M., Canavy I., Blann A., et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93 (1999) 2951-2958
18. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
19. Stewart D.J., Zhao Y.D., and Courtman D.W. Cell therapy for pulmonary hypertension: what is the true potential of endothelial progenitor cells?. Circulation 109 (2004) 172-173
20. Campbell A.I., Kuliszewski M.A., and Stewart D.J. Cell-based gene transfer to the pulmonary vasculature: endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. Am J Respir Cell Mol Biol 21 (1999) 567-575
21. Keith I.M., Tjen-ALooi S., Kraiczi H., et al. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 279 (2000) H1571-H1578
22. Juaneda C., Dumont Y., and Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 21 (2000) 432-438
23. Bivalacqua T.J., Hyman A.L., Kadowitz P.J., Paolocci N., Kass D.A., and Champion H.C. Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. Influence of gene transfer in vivo. Regul Pept 108 (2002) 129-133
24. Keith I.M. The role of endogenous lung neuropeptides in regulation of the pulmonary circulation. Physiol Res 49 (2000) 519-537
25. Boyer J.C., Christen M.O., Balmes J.L., et al. Calcitonin gene-related peptide-induced relaxation of isolated human colonic smooth muscle cells through different intracellular pathways. Biochem Pharmacol 56 (1998) 1097-1104
26. Uddmann R., Edvinsson I., Ekblad E., et al. Calcitonin gene-related peptide: perivascular distribution and vasodilatory effects. Regul Pept 15 (1986) 1-23
27. Houde C., Bohn D.J., Freedom R.M., et al. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 70 (1993) 461-468
28. Barst R.J., Rubin L.J., Long W.A., et al., The Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334 (1996) 296-302
29. Ziegler J.W., Ivy D.D., Wiggins J.W., et al. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med 158 (1998) 1388-1395
30. Oz M.C., and Ardehali A. Collective review: perioperative uses of inhaled nitric oxide in adults. Heart Surg Forum 7 (2004) 584-589
31. 1 during heart transplantation. Anesth Analg 90 (2000) 523-530